AuditorNov 6, 2026, 05:26 PM
Shuttle Pharmaceuticals Appoints New Independent Auditor
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. has engaged Bush & Associates CPA LLC as its new independent registered public accounting firm, effective November 2, 2026. This follows the prior dismissal of Forvis Mazars, LLP. Bush & Associates will be responsible for auditing the company's financial statements for the fiscal year ending December 31, 2026, and reviewing interim financial statements for the first three quarters of 2027. There were no consultations with Bush & Associates on significant accounting or auditing matters prior to their engagement.
Key Highlights
- Shuttle Pharmaceuticals Holdings, Inc. engaged Bush & Associates CPA LLC as its new independent registered public accounting firm.
- Bush & Associates will audit the Company’s financial statements for the fiscal year ending December 31, 2026.
- Bush & Associates will review interim financial statements for the fiscal quarters ending March 31, 2027, June 30, 2027, and September 30, 2027.
- The previous auditor, Forvis Mazars, LLP, was dismissed effective following the filing of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026.
Price Impact
More from SHPH